Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
flu vaccine
Biotech
CureVac, chasing Moderna mRNA flu shot, hits similar problems
CureVac and GSK have come up against the same problem as Moderna when it comes to the "historically challenging" B strains of influenza.
James Waldron
Apr 4, 2024 9:30am
Would you eat a lollipop without candy? The flu virus won't
Jan 16, 2024 9:02am
First-gen mRNA flu vaccines 'will not win,' Sanofi execs admit
Jun 30, 2023 9:10am
Racing Moderna, Pfizer starts phase 3 trial of mRNA flu vaccine
Sep 14, 2022 9:05am
NIH moves closer to vaccine holy grail: a universal flu shot
Jul 13, 2022 2:00pm
Moderna's Bancel has 'never been as busy' amid M&A talks
May 4, 2022 11:19am